International Case Reports Journal (ISSN: 2770-9647) | Volume 2, Issue 5 | Case Series | Open Access

Melanodermatitis Toxica Associated With the Use of Secukinumab for the Treatment of Plaque Psoriasis: A Case Report

Artur Antônio Duarte*

1Clinic of Skin Diseases DW, São Paulo, São Paulo, Brazil 2Collaborating Physician at the Collagenosis, Brazil 3Resident Doctor at the Dermatology Service at Santo Amaro Medical School, Brazil

*Correspondence to: Artur Antônio Duarte 

Fulltext PDF

Abstract

A 43-years-old woman, phototype II, with a previous diagnosis of plaque psoriasis, started follow-up at the Dermatology service of University Santo Amaro in February 2018. Dermatological examination showed scaly erythematous plaques infiltrated along areas of extension, back, abdomen and scalp. The patient denied any joint complaints. She also presented hidradenitis suppurativa (Hurley 1-2) and hypothyroidism as comorbidities. She reported previous treatments for more than 2 years with acitretin, suspended due to the onset of severe diffuse alopecia; infliximab, discontinued due to early treatment failure; and etanercept, suspended due to drug unavailability.

Keywords:

Citation:

Artur Antônio Duarte. Melanodermatitis Toxica Associated With the Use of Secukinumab for the Treatment of Plaque Psoriasis: A Case Report. Int Case Rep Jour. 2022;2(5):1-3.